Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease


YILMAZ Y., ULUKAYA E., Gul O. O. , Arabul M., Gul C. B. , ATUĞ Ö., ...More

CLINICAL BIOCHEMISTRY, vol.42, no.9, pp.802-807, 2009 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 42 Issue: 9
  • Publication Date: 2009
  • Doi Number: 10.1016/j.clinbiochem.2009.02.003
  • Journal Name: CLINICAL BIOCHEMISTRY
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.802-807
  • Keywords: Fatty liver, Biological markers, Receptor for advanced glycation endproducts (RAGE), Enzyme-linked immunosorbent assay, END-PRODUCTS AGES, INSULIN-RESISTANCE, SERUM-LEVELS, RAGE, FORM, PATHOGENESIS, GALECTIN-3, PROTEIN

Abstract

Objectives: Levels of soluble receptor for advanced glycation endproducts (sRAGE) have been linked to several components of the metabolic syndrome. We tested the hypothesis that plasma levels of sRAGE may be associated with non-alcoholic fatty liver disease.